Dr Reddy's launches Sildenafil tablets in US

Sildenafil tablets are used to treat erectile dysfunction and pulmonary arterial hypertension

Following the approval by the United States Food and Drug Administration for its abbreviated new drug application (ANDA), Hyderabad-based pharmaceutical major Laboratories Limited has launched in the US market on November 16, 2012.

A bioequivalent generic version of Revatio, Sildenafil tablets are used to treat erectile dysfunction and pulmonary arterial hypertension (PAH).

The Revatio brand had US sales of approximately $338.67 million for the most-recent 12 months ending September 2012, according to IMS Health, Dr Reddy's said in a filing to the BSE on Monday.

Dr Reddy's scrip is currently trading at Rs 1,769 on the BSE, up 0.66%, over the previous close of Rs 1,757.35 a share.

image
Business Standard
177 22
Business Standard

Dr Reddy's launches Sildenafil tablets in US

Sildenafil tablets are used to treat erectile dysfunction and pulmonary arterial hypertension

K Rajani Kanth  |  Hyderabad 



Following the approval by the United States Food and Drug Administration for its abbreviated new drug application (ANDA), Hyderabad-based pharmaceutical major Laboratories Limited has launched in the US market on November 16, 2012.

A bioequivalent generic version of Revatio, Sildenafil tablets are used to treat erectile dysfunction and pulmonary arterial hypertension (PAH).

The Revatio brand had US sales of approximately $338.67 million for the most-recent 12 months ending September 2012, according to IMS Health, Dr Reddy's said in a filing to the BSE on Monday.

Dr Reddy's scrip is currently trading at Rs 1,769 on the BSE, up 0.66%, over the previous close of Rs 1,757.35 a share.

RECOMMENDED FOR YOU

Dr Reddy's launches Sildenafil tablets in US

Sildenafil tablets are used to treat erectile dysfunction and pulmonary arterial hypertension

A bioequivalent generic version of Revatio, Sildenafil tablets are used to treat erectile dysfunction and pulmonary arterial hypertension (PAH).

Following the approval by the United States Food and Drug Administration for its abbreviated new drug application (ANDA), Hyderabad-based pharmaceutical major Laboratories Limited has launched in the US market on November 16, 2012.

A bioequivalent generic version of Revatio, Sildenafil tablets are used to treat erectile dysfunction and pulmonary arterial hypertension (PAH).

The Revatio brand had US sales of approximately $338.67 million for the most-recent 12 months ending September 2012, according to IMS Health, Dr Reddy's said in a filing to the BSE on Monday.

Dr Reddy's scrip is currently trading at Rs 1,769 on the BSE, up 0.66%, over the previous close of Rs 1,757.35 a share.

image
Business Standard
177 22
Widgets Magazine

More News

  • Signs of realty revival ahead of festive season Signs of realty revival ahead of festive season
  • Amit Chandra Bain Capital's Amit Chandra joins Tata Sons board
Widgets Magazine
Widgets Magazine

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard